Contents

Current Pharmaceutical Design, Volume 18 - Number 4




Basic Symptoms and the Prediction of First-Episode Psychosis

, 18(4): 351 - 357

Frauke Schultze-Lutter, Stephan Ruhrmann, Paolo Fusar-Poli, Andreas Bechdolf, Benno G. Schimmelmann and Joachim Klosterkotter


DOI: 10.2174/138161212799316064


Rationale and First Results of Developing At-Risk (Prodromal) Criteria for Bipolar Disorder

, 18(4): 358 - 375

A. Bechdolf, A. Ratheesh, S. J. Wood, T. Tecic, P. Conus, B. Nelson, S. M. Cotton, A. M. Chanen, G. P. Amminger, S. Ruhrmann, F. Schultze-Lutter, J. Klosterkotter, P. Fusar Poli, A. R. Yung, M. Berk and P. D. McGorry


DOI: 10.2174/138161212799316226





Neurocognition in the Psychosis Risk Syndrome: A Quantitative and Qualitative Review

, 18(4): 399 - 415

Anthony J. Giuliano, Huijun Li, Raquelle I. Mesholam-Gately, Shannon M. Sorenson, Kristen A. Woodberry and Larry J. Seidman


DOI: 10.2174/138161212799316019




Relationship Between Gyrification and Functional Connectivity of the Prefrontal Cortex in Subjects at High Genetic Risk of Schizophrenia

, 18(4): 434 - 442

Maria R. Dauvermann, Prerona Mukherjee, William T. Moorhead, Andrew C. Stanfield, Paolo Fusar-Poli, Stephen M. Lawrie and Heather C. Whalley


DOI: 10.2174/138161212799316235







Cingulate Volume Abnormalities in Emerging Psychosis

, 18(4): 495 - 504

Michel Rothlisberger, Anita Riecher-Rossler, Jacqueline Aston, Paolo Fusar-Poli, Ernst-Wilhelm Radu and Stefan Borgwardt


DOI: 10.2174/138161212799316316


Biochemical Markers of Impending Psychosis

, 18(4): 505 - 509

Enzo Emanuele, Valentina Martinelli, Vera Abbiati, Paolo Fusar-Poli and Pierluigi Politi


DOI: 10.2174/138161212799316000


Genetic Vulnerability to Psychosis and Cortical Function: Epistatic Effects between DAAO and G72

, 18(4): 510 - 517

Mechelli Andrea, Fusar-Poli Paolo, Prata Diana, Papagni Sergio Alessandro, Tognin Stefania, Kambeitz Joseph, Fu Cynthia, Picchioni Marco, Walshe Muriel, Toulopoulou Timothea, Bramon Elvira, Murray Robin and McGuire Philip


DOI: 10.2174/138161212799316037



Stress and the Prodromal Phase of Psychosis

, 18(4): 527 - 533

Carrie W. Holtzman, Daniel I. Shapiro, Hanan D. Trotman and Elaine F. Walker


DOI: 10.2174/138161212799316280




Pharmacological Prevention and Treatment in Clinical At-Risk States for Psychosis

, 18(4): 550 - 557

Stephan Ruhrmann, Joachim Klosterkotter, Mitja Bodatsch, Andreas Bechdolf, Benno Graf Schimmelmann, Alexandra Nikolaides, Desiree Hilboll and Frauke Schultze-Lutter


DOI: 10.2174/138161212799316172




Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study

, 18(4): 570 - 575

Gregor E. Berger, Stephen J. Wood, Margaret Ross, Clare A. Hamer, R. Mark Wellard, Gaby Pell, Lisa Phillips, Barnaby Nelson, G. Paul Amminger, Alison R. Yung, Graeme Jackson, Dennis Velakoulis, Christos Pantelis, Husseini Manji and Patrick D McGorry


DOI: 10.2174/138161212799316163


Polyunsaturated Fatty Acids in Emerging Psychosis

, 18(4): 576 - 591

Nilufar Mossaheb, Monika Schloegelhofer, Miriam R. Schaefer, Paolo Fusar-Poli, Stefan Smesny, Pat McGorry, Gregor Berger and G. Paul Amminger


DOI: 10.2174/138161212799316055




Ethical Implications for Clinical Practice and Future Research in “At Risk” Individuals

, 18(4): 606 - 612

Fiza Singh, Heline Mirzakhanian, Paolo Fusar-Poli, Camilo de la Fuente-Sandoval and Kristin S. Cadenhead


DOI: 10.2174/138161212799316262



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science